HIV awareness campaigns promise screening boost in Peru, Nicaragua:
This article was originally published in Clinica
The Peruvian health ministry is due to launch next week an AIDS awareness campaign, in a bid to reduce HIV transmission rates. The campaign, headed by Dr Nora Ojeda Celi, will be targeted at the younger age groups and women: HIV prevalence is highest in the 25-29-year range, which accounted for 4,100 of the almost 20,000 cases registered at April 2007, while over the last 20 years, HIV infection among women has increased from 9% to 25%. In Nicaragua, where up to 20,000 people are thought to be infected, the national HIV/AIDS association is considering a similar initiative, with a focus on urging people to come forward for testing.
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.